Breaking News

Mural Health, ICON Partner to Enhance Site Experience in Clinical Trials

Will use Mural Link’s functionality related to clinical trial participant support services, communication tools, and reporting and analytics capabilities. 

By: Kristin Brooks

Managing Editor, Contract Pharma

Mural Health Technologies, Inc., a clinical trial technology company, and ICON plc, a global CRO, partnered to use the participant management and payments platform, Mural Link.

ICON will utilize Mural Link’s functionality related to clinical trial participant payments, tax management, travel and concierge support, site-participant communication tools, and novel reporting and analytics capabilities. 

“From our very first conversations with ICON, we were highly impressed by their commitment to patient care and innovation,” said Sam Whitaker, CEO of Mural Health. “This partnership represents a shared vision of removing barriers to trial participation and advancing participation financial neutrality, while eliminating the need for site staff to manage highly manual, error-prone, and time-consuming administrative activities.”

“Mural Health’s range of payment methods, unique approach to payment structure, and introduction of a fee-free participant environment are important additions to how we deliver care to patients,” said Dr Gareth Milborrow, Executive Vice President, Business Operations, ICON. “We look forward to bringing these to our customers and, importantly, to delivering very tangible benefits to our patients and sites.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters